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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Active vitamin D 
prevents calcification 
in mice with CKD
Previous studies have yielded conflict-
ing results on the effects of vitamin D 
receptor agonists (VDRAs) on vascular 
calcification in chronic kidney disease 
(CKD). Lau et al. studied a murine 
CKD model in which mice were fed 
high-phosphorus diets and developed 
aortic medial calcification. Interest-
ingly, VDRA treatment reduced aortic 
calcification without changing para-
thyroid hormone or calcium levels. 
Furthermore, VDRAs increased phos-
phorus excretion, reduced fibroblast 
growth factor-23 levels, and increased 
serum and urine klotho and osteo-
pontin expression in vascular smooth 
muscle cells. These provocative data 
suggest that VDRAs may prevent 
vascular calcification in CKD, in part 
via klotho and osteopontin upregula-
tion. See page 1261.
eGFR variability 
predicts death
Though cross-sectional studies have 
established an association between 
reduced estimated glomerular filtration 
rate (eGFR) and increased risk of mortal-
ity, it is not known whether eGFR vari-
ability itself is associated with mortality. 
As they report in this issue, two groups 
investigated the relationship between 
eGFR variability and mortality. Al-Aly 
and colleagues studied this relationship 
in a cohort of 51,304 US veterans with 
eGFR less than 60 ml/min at the end 
of follow-up who had had at least two 
measurements in the preceding 2 years. 
They found that the tertile with the high-
est eGFR variability had a hazard ratio of 
1.34 for death compared with the lowest 
tertile. Perkins et al. examined a cohort 
of 3361 patients with stage 3 CKD and a 
minimum of four outpatient eGFR meas-
urements over 2 years. In findings simi-
lar to those of Al-Aly, they found that the 
quartile with the highest eGFR variability 
had a 1.4-fold higher risk of death than 
the lowest quartile. These studies strongly 
suggest that increased eGFR variability 
in patients with CKD is associated with 
increased risk of death. Additional studies 
are needed to determine the factors medi-
ating this increased risk. See page 1332.
Is there a GI–renal 
natriuretic axis?
Invest igators  have  prop os e d  a 
gastrointestinal (GI)–renal axis in 
which a GI-based sensor responds to 
dietary sodium by releasing a natriuretic 
signal. Preston and co-workers present 
an elegant study in which they directly 
test this hypothesis. Fifteen healthy 
volunteers were given equivalent oral or 
intravenous sodium loads during high- or 
low-salt diets. There was no difference in 
sodium excretion between the different 
experimental groups. Moreover, serum 
levels of prouroguanylin and uroguanylin, 
putative mediators of the GI–renal 
signaling axis, did not differ among 
treatment groups and did not correlate 
with sodium excretion. These results 
argue against the existence of a GI–renal 
natriuretic signaling axis that governs 
dietary sodium excretion. See page 1313.
